Researchers
Miljković, Đorđe
Results 1-20 of 212
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2026 | Imunske ćelije pluća imaju aktivnu ulogu u patogenezi autoimunosti usmerene protiv centralnog nervnog sistema | Stegnjaić, Goran | Other | Mp. category will be shown later |
| 2026 | Eksperimentalni autoimunski encefalomijelitis indukovan u DA pacova bez korišćenja adjuvansa kao model multiple skleroze | Stanisavljević, Suzana | Conference Paper | Mp. category will be shown later |
| 2026 | Slučajnost nauke | Miljković, Đorđe | Conference Paper | Mp. category will be shown later |
| 2026 | Changes in Adaptive Immunity in Autoimmune Diseases and Aging: Shared Features, Key Differences, and Implications for Immune Vulnerability | Jevtić, Bojan | Reviews | 21M21 |
| 2026 | Minociklin ostvaruje antiencefalitogeno dejstvo ograničavajući CD4+CD11bc+ ćelije | Milosavljević, Zorana | Conference Paper | Mp. category will be shown later |
| 2025 | Amelioration of Central Nervous System Autoimmunity Through FFAR2 Agonism Is Associated With Changes in Gut Microbiota | Jevtić, Bojan | Article | 21M21 |
| 2025 | Multiple low dose streptozotocin-induced diabetes as a model for studying autoimmune diabetes in humans | Koprivica, Ivan | Reviews | 22M22 |
| 2025 | Sepsis prevents the development of experimental type 1 diabetes![]() | Stegnjaić, Goran | Article | 21M21 |
| 2025 | Assessing Peripheral Blood Biomarkers and Predictive Patterns in Multiple Sclerosis Using Cytokines and Immune Gene Expression Profiles in Ocrelizumab-Treated Patients: Tracking Tumor Necrosis Factor![]() | Jevtić, Bojan | Article | 21M21 |
| 2025 | Vaccine-Induced Humoral and Cellular Response to SARS-CoV-2 in Multiple Sclerosis Patients on Ocrelizumab![]() | Drulović, Jelena | Article | 21M21 |
| 2025 | Development of bile acid-derived compounds as dual NRF2 activators and FXR modulators with anticancer potential | Cvijić, Sergej; Bjedov, Srđan; Kovačević, Ivana; Smolić, Martina; Hefer, Marija; Petrović, Ana; Smolić, Robert; Miljković, Đorđe | Conference Paper | Mp. category will be shown later |
| 2025 | The mechanism of action of HYCO-3, an Nrf2 activator/CO releaser hybrid in inhibiting autoimmune disease development in mouse models | Mićanović, Dragica | Conference Paper | Mp. category will be shown later |
| 2024 | Novel FFAR2 agonist prevents development of type 1 diabetes in C57BL/6 mice | Jonić, Natalija | Conference Paper | Mp. category will be shown later |
| 2024 | Ethyl pyruvate ameliorates acute respiratory distress syndrome in mice![]() | Mićanović, Dragica | Article | 21aM21a |
| 2024 | Immunomodulatory effects of HYCO-3, a dual action CO-releaser/Nrf2 activator![]() | Stegnjaic, Goran | Article | 22M22 |
| 2024 | Increased regulatory activity of intestinal innate lymphoid cells type 3 (ILC3) prevents experimental autoimmune encephalomyelitis severity![]() | Lazarević, Milica | Article | 21a+M21a+ |
| 2024 | Complete Freund's adjuvant as a confounding factor in multiple sclerosis research![]() | Lazarevic, Milica N | Reviews | 21M21 |
| 2024 | Pharmacological activation of free fatty acid receptor 2 in intestinal type 3 innate lymphoid cells ameliorates experimental autoimmune encephalomyelitis | Lazarević, Milica | Conference Paper | Mp. category will be shown later |
| 2024 | Anti-Neuroinflammatory Effects of a Novel Bile Acid Derivative | Bjedov, Srđan | Article | 21M21 |
| 2024 | NRF2 plays a crucial role in the tolerogenic effect of ethyl pyruvate on dendritic cells![]() | Stanisavljević, Suzana | Article | 21M21 |
